Human vsmcs
Human vascular smooth muscle cells (VSMCs) are primary cells derived from human vascular tissue. They are a critical component of the vascular system and play a key role in maintaining vascular tone and structure.
Lab products found in correlation
7 protocols using human vsmcs
VSMC Transfection and SIRT5 Overexpression
Culturing HUVECs and Human VSMCs
Ox-LDL-Induced In Vitro Atherosclerosis Model
Modulating miR-183-5p Expression in VSMCs
MiR-183-5p Regulation in VSMCs
As previous study described, cells were transfected with 100 nM miR-183-5p agomir or antagomir, or agomir NC, antagomir NC to regulate the expression level of miR-183-5p by using Lipofectamine 3000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions [18] . 48h post-transfection, cells were collected for further experiments. To investigate ox-LDL regulation on miR-183-5p expression, VSMCs were treated with ox-LDL (40 μg/ml).
Overexpression of LIPCAR in VSMCs
miR-25 Regulation of CDK6 in VSMCs
Vectors and cell culture. The pcDNA-CDK6 vector was purchased from Sigma-Aldrich (Oakville, ON, Canada). The CDK6 3'UTR sequence with the binding site for miR-25 was cloned into the pMIR-REPORT luciferase construct (Ambion Life Technologies, Carlsbad, CA, USA). The mutant construct of CDK6 3'UTR was generated using the QuikChange Site-Directed Mutagenesis kit (Agilent Technologies, Inc., Santa Clara, CA, USA). The reagents for cell culture (fetal bovine serum, penicillin and streptomycin) were purchased from Gibco Life Technologies (Carlsbad, CA, USA). Human VSMCs were obtained from the American Type Culture Collection (Manassas, VA, USA) and cultured in the medium 231 supplemented with smooth muscle cell growth supplement (Gibco Life Technologies) at 37˚C in a humidified atmosphere of 95% air and 5% CO 2 .
Cell transfection. The miR-25 mimics and the control were synthesized by Shanghai GenePharma Co., Ltd. (Shanghai, China) and transfected into the cells to a final oligonucleotide concentration of 20 nmol/l. All cell transfections were introduced using DharmaFECT 1 reagent (GE Healthcare Biosciences, Pittsburgh, PA, USA) according to the manufacturer's instructions.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!